Parathyroid hormone and cardiac function in male patients hospitalized for heart failure

    Authors

    Keywords

    heart failure, left ventricular diastolic function, left ventricular ejection fraction, men, parathyroid hormone

    DOI

    https://doi.org/10.15836/ccar2025.105

    Full Text

    **Introduction**: Due to its role in calcium and phosphate metabolism and homeostasis, increased levels of parathyroid hormone (PTH) have been associated with increased cardiovascular morbidity through mechanisms such as enhanced ectopic calcification, systemic and local inflammation, and adverse cardiac remodelling (1). At the same time, patients with heart failure (HF) have increased levels of PTH which may result from activation of the renin-angiotensin-aldosterone system and the use of loop diuretics (2, 3). A positive correlation between PTH and NT-proBNP has also been reported (4). **Patients and Methods**: Baseline characteristics, prehospital cardiovascular medications, cardiovascular risk factors, laboratory findings on admission, serum concentrations of PTH and echocardiographic parameters were prospectively collected on 213 male patients hospitalized for episode of acute HF. The left ventricular (LV) ejection fraction (LVEF) and LV diastolic dysfunction (LVDD) were assessed in accordance with the current guidelines. **Results:** The mean age of the study population was 74.7±8.1 years, creatinine clearance 55.8±19.5 mL/min/1.73 m2, LVEF 46.1±12.9%, median LVDD was grade 3 (interquartile range 2–3) and median PTH was 7.87 pmol/L (interquartile range 5.42–11.26). Compared to their counterparts, patients with hypertension (p=0.011) and previous myocardial infarction (p=0.047) had higher serum PTH levels, whereas there was no difference according to diabetes mellitus (p=0.15) or smoking (p=0.76). Positive linear correlations were observed when assessing the crude relationship between PTH and age (p<0.0001) or LVDD (p=0.002). PTH inversely correlated with creatinine clearance (p<0.0001) or LVEF (**Figure 1**). The multivariable models, which included adjustment for baseline characteristics and cardiovascular covariates, showed an independent predictive association of PTH for both LVEF (ß=-0.336, p<0.0001) and LVDD (ß=0.174, p=0.03). FIGURE 1. Scatterplot of the association between the left ventricular ejection fraction (LVEF) and serum concentration of parathyroid hormone in male patients with heart failure. A significant negative correlation between the variables was observed in the study population. **Conclusions**: There is a possibility that PTH is an independent adverse factor of the complex network of pathophysiological processes impacting the myocardium, LVEF and LVDD. PTH is likely another hormone playing a role in the multiple hormone disbalance syndrome which accompanies HF.

    Literature

    1. Brown SJ, Ruppe MD, Tabatabai LS. The Parathyroid Gland and Heart Disease. Methodist DeBakey Cardiovasc J. 2017 April-June;13(2):49–54. https://doi.org/10.14797/mdcj-13-2-49
    2. Corapi KM, McMahon GM, Wenger JB, Seifter JL, Bhan I. Association of loop diuretic use with higher parathyroid hormone levels in patients with normal renal function. JAMA Intern Med. 2015 January;175(1):137–8. https://doi.org/10.1001/jamainternmed.2014.5857
    3. Tomaschitz A, Ritz E, Pieske B, Fahrleitner-Pammer A, Kienreich K, Horina JH, et al. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res. 2012 April 1;94(1):10–9. https://doi.org/10.1093/cvr/cvs092
    4. Nägele MP, Barthelmes J, Kreysing L, Haider T, Nebunu D, Ruschitzka F, et al. Endocrine hormone imbalance in heart failure with reduced ejection fraction: A cross-sectional study. Health Sci Rep. 2022 October 28;5(6):e880. https://doi.org/10.1002/hsr2.880
    Cardiologia Croatica
    Back to search

    Parathyroid hormone and cardiac function in male patients hospitalized for heart failure

    Extended Abstract
    Issue5-6
    Published
    Pages105
    PDF via DOIhttps://doi.org/10.15836/ccar2025.105
    heart failure
    left ventricular diastolic function
    left ventricular ejection fraction
    men
    parathyroid hormone

    Authors

    Viktor Čulić*ORCIDUniversity Hospital Centre Split, Split, Croatia
    Željko BušićORCIDUniversity of Split School of Medicine, Split, Croatia
    Ivan VelatORCIDUniversity of Split School of Medicine, Split, Croatia

    *Correspondence email: viktor.culic@st.t-com.hr

    Full Text

    Introduction: Due to its role in calcium and phosphate metabolism and homeostasis, increased levels of parathyroid hormone (PTH) have been associated with increased cardiovascular morbidity through mechanisms such as enhanced ectopic calcification, systemic and local inflammation, and adverse cardiac remodelling (1). At the same time, patients with heart failure (HF) have increased levels of PTH which may result from activation of the renin-angiotensin-aldosterone system and the use of loop diuretics (2, 3). A positive correlation between PTH and NT-proBNP has also been reported (4).

    Patients and Methods: Baseline characteristics, prehospital cardiovascular medications, cardiovascular risk factors, laboratory findings on admission, serum concentrations of PTH and echocardiographic parameters were prospectively collected on 213 male patients hospitalized for episode of acute HF. The left ventricular (LV) ejection fraction (LVEF) and LV diastolic dysfunction (LVDD) were assessed in accordance with the current guidelines.

    Results: The mean age of the study population was 74.7±8.1 years, creatinine clearance 55.8±19.5 mL/min/1.73 m2, LVEF 46.1±12.9%, median LVDD was grade 3 (interquartile range 2–3) and median PTH was 7.87 pmol/L (interquartile range 5.42–11.26). Compared to their counterparts, patients with hypertension (p=0.011) and previous myocardial infarction (p=0.047) had higher serum PTH levels, whereas there was no difference according to diabetes mellitus (p=0.15) or smoking (p=0.76). Positive linear correlations were observed when assessing the crude relationship between PTH and age (p<0.0001) or LVDD (p=0.002). PTH inversely correlated with creatinine clearance (p<0.0001) or LVEF (Figure 1). The multivariable models, which included adjustment for baseline characteristics and cardiovascular covariates, showed an independent predictive association of PTH for both LVEF (ß=-0.336, p<0.0001) and LVDD (ß=0.174, p=0.03).

    FIGURE 1. Scatterplot of the association between the left ventricular ejection fraction (LVEF) and serum concentration of parathyroid hormone in male patients with heart failure. A significant negative correlation between the variables was observed in the study population.

    Conclusions: There is a possibility that PTH is an independent adverse factor of the complex network of pathophysiological processes impacting the myocardium, LVEF and LVDD. PTH is likely another hormone playing a role in the multiple hormone disbalance syndrome which accompanies HF.

    Literature

    1. 1.
      Brown SJ, Ruppe MD, Tabatabai LS. The Parathyroid Gland and Heart Disease. Methodist DeBakey Cardiovasc J. 2017 April-June;13(2):49–54.DOI
    2. 2.
      Corapi KM, McMahon GM, Wenger JB, Seifter JL, Bhan I. Association of loop diuretic use with higher parathyroid hormone levels in patients with normal renal function. JAMA Intern Med. 2015 January;175(1):137–8.DOI
    3. 3.
      Tomaschitz A, Ritz E, Pieske B, Fahrleitner-Pammer A, Kienreich K, Horina JH, et al. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res. 2012 April 1;94(1):10–9.DOI
    4. 4.
      Nägele MP, Barthelmes J, Kreysing L, Haider T, Nebunu D, Ruschitzka F, et al. Endocrine hormone imbalance in heart failure with reduced ejection fraction: A cross-sectional study. Health Sci Rep. 2022 October 28;5(6):e880.DOI